Assays for resistance to echinocandin-class drugs

Details for Australian Patent Application No. 2012230095 (hide)

Owner Merck Sharp & Dohme Corp. University of Medicine and Dentistry of New Jersey

Inventors Douglas, Cameron M.; Perlin, David S.; Park, Steven; Kelly, Rosemarie; Parent, Stephen A.; Kahn, Jennifer Nielsen

Agent Spruson & Ferguson

Pub. Number AU-A-2012230095

Parent 2006272568

Filing date 27 September 2012

Wipo publication date 18 October 2012

International Classifications

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07H 19/00 Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

18 October 2012 Application Open to Public Inspection

  Published as AU-A-2012230095

18 October 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012230096-Method and apparatus for providing a virtual electric utility

2012230094-Hemodialysis catheter with improved side opening design